Investing in the Vitamin Industry through DNA Genetics

Take a look at Glucose Health, Inc. (OTC Pink: GLUC).

Google Ads

An article in Banyan Hill discussed a better way to buy Vitamins.  A company called Baze, prides themselves on being the only FDA approved at-home blood nutrient test.  They are aiming to take the guesswork out of nutrition supplements by using your DNA to customize vitamins that are optimum for your body. 

One way to take advantage of the continued advances of DNA-Specific health is through an ETF called Ark Genomic Revolution ETF (NYSE: ARKG). 

The ETF is up 300% over the past few years and 50% of that over the past few months.  With holdings like Inovo Pharmaceuticals (NYSE: INO), Sorrento Therapeutics (NASDAQ: SRNE) and Tracon Pharmaceuticals (NASDAQ: TCON), and Ocugen, Inc. (NASDAQ: OCGN), It’s hard not to believe it.  

But, surprisingly missing in this ETF is exposure to the diabetic space.  

Take a look at Glucose Health, Inc. (OTC Pink: GLUC).  The Company manufacturers nutritional beverages for the diabetic-adult nutrition consumer retail category under the registered trademark GLUCODOWN®. GLUCODOWN® is infused with a special form of diabetic fiber demonstrated in more than 20 clinical studies to help maintain healthy blood sugar levels and regular digestive health.

Glucose GLUC

During the 2nd quarter, Glucose Health, Inc. experienced unprecedented consumer demand for GLUCODOWN® – in particular at (NASDAQ: AMZN).  By mid-June it became apparent to management that GLUCODOWN® inventories at Amazon were rapidly depleting and the Company responded quickly by placing new production orders.  Other retailers distributing GLUCODOWN® include CVS Health (NYSE: CVS), Walmart (NYSE: WMT).

What are the revenues of this company going to look like when the latest GLUCODOWN® sales numbers are reported for Q3 and Q4? 

Google Ads

Over the past 12 months, GLUC has seen a range of approximately $.20 – $1.90 per share and with only 12.5 million shares outstanding, GLUC could be the best value in the diabetes space and should be on everybody’s watch list. 

About is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. has motivation by means of either self-marketing or has been compensated by or for a company or companies discussed in this article. has been compensated eight thousand one hundred dollars in consideration for its work with Glucose Health, Inc. through the date this was published. may or may not receive additional compensation, details about which can be found in our full disclosure, which can be found here  You can easily loose money investing in highly speculative small cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the website.